Donate Now
Tuberous Sclerosis Australia
Menu
  • TSC Information
    • Signs and Symptoms of TSC
      • Brain
      • Epilepsy
      • Eyes
      • Genetics
      • Heart
      • Kidneys
      • Lungs
      • Skin
      • TAND – Behaviour, learning and mental health
    • TSC Diagnosis, Management and Treatment
      • New Diagnosis
      • Diagnostic Criteria for TSC
      • Surveillance and management guidelines for TSC
      • mTOR inhibitors in TSC
      • Life expectancy in tuberous sclerosis complex
      • A guide to using Facebook
      • Financial challenges of TSC
    • Close
  • Our Stories
    • LilyLily, an inspiration
    • JoshuaJoshua: Doing the best that we can
    • DavidDavid: Getting on with life
    • Read more stories from people living with TSC
    • Close
  • Stay Up-to-date
    • All the latest news
    • Events
    • Read our magazine
    • Research news
    • Subscribe to our enewsletter
    • Close
  • About Us
    • Our team
    • Strategic plan
    • TSA Survey 2019
    • What’s next?
    • Elizabeth Pinkerton Memorial Award
    • Annual reports
    • Policies
    • Contact us
    • Close
  • Support Us
    • Donate
    • Fundraise for us
    • Comedy for a Cure
    • TSC Heroes
    • Lizzie’s Lunch
    • #Heroes4TSC
    • Membership
      • Renew
      • Close
    • Leave a bequest
    • Gifts in memory
    • Volunteer
    • Close
  • TSA Nurse
Home » All the Latest News » epilepsy

epilepsy

Understanding TSC associated epilepsy through the TOSCA natural history study
21 Mar 2019

Understanding TSC associated epilepsy through the TOSCA natural history study
by Clare Stuart | Category: Research News | 0

This study helps us understand epilepsy in people with tuberous sclerosis complex (TSC) by analysing the experiences of 1852 people with both TSC and epilepsy involved in the TOSCA project.

epilepsy

More information

  • About the campaign
  • Why the wave?
  • Register my #Tatts4TSC event
  • Buy a tattoo
  • Global Awareness Day
  • TSA Nurse

About TSA

All donations $2 and over are tax deductible.

Tuberous Sclerosis Australia Inc is an incorporated association in New South Wales.
Incorporation number Y07116-42
ABN 20 681 174 734
Registered Charity CC25313

TSA has received funding from Novartis Pharmaceuticals. Our policy on working with pharmaceutical companies describes how we maintain our independence and integrity.

Disclaimer

The information on this website is intended to provide basic information about Tuberous Sclerosis Complex (TSC). It is not intended to, and it should not, constitute medical or other advice.

Readers are warned not to take any action without first seeking medical advice.

The TSA Privacy Policy explains how we handle your personal information.

To our supporters

Thank You TSA receives no ongoing government funding and relies on your generosity.

© 2020 Tuberous Sclerosis Australia